TRANSARTERIAL CHEMOEMBOLIZATION COMPARED WITH STEREOTACTIC BODY RADIATION THERAPY OR STEREOTACTIC ABLATIVE RADIATION THERAPY IN TREATING PATIENTS WITH RESIDUAL OR RECURRENT LIVER CANCER UNDERGONE INITIAL TRANSARTERIAL CHEMOEMBOLIZATION: